Increased serum levels of pentosidine but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy [21]

Diabetes Care

Volumn 22, Issue 5, 1999, Pages 877-878

  Daimon, Makoto ^a   Ono, Yuri ^b   Saito, Tamotsu ^a   Yamaguchi, Hiroshi ^a   Hirata, Akihiko ^a   Ohnuma, Hiroshi ^a   Igarashi, Masahiko ^a   Eguchi, Hideyuki ^a   Manaka, Hideo ^a   Kato, Takeo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Sapporo Shakaihoken General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; LYSINE DERIVATIVE; PENTOSIDINE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE MARKER; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA;

ALBUMINURIA; ARGININE; BIOLOGICAL MARKERS; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LYSINE; MIDDLE AGED; REFERENCE VALUES;

EID: 0032898675     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.5.877     Document Type: Letter

References (6)

1. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complication. N Engl J Med 318:1315-1321, 1988
2. Miyata S, Monnier VM: Immunohistochemical detection of advanced glycosylation end products in diabetic tissue using monoclonal antibody to pyrraline. J Clin Invest 89:1102-1112, 1992
3. Nicholls K, Mandel TE: Advanced glycosylation end-products in experimental murine diabetic nephropathy. Lab Invest 60:486-491, 1989
4. Makino H, Shikata K, Hironaka K, Kushiro M, Yamasaki Y, Sugimoto H, Ota Z, Araki N, Horiuchi S: Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int 48:515-526, 1995
5. Vlassara H, Striker LJ, Teichberg S, Fuh H, Ming Li Y, Steffes M: Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A 91:11704-11708, 1994
6. Ono Y, Aoki S, Ohnishi K, Yasuda T, Kawano K, Tsukada Y: Increased serum levels of advanced glycation end products in NIDDM patients with diabetic complications (Letter). Diabetes Care 21:1027, 1998